Non Small-cell Lung Cancer Clinical Trial
Official title:
Liquid Biopsy to Distinguish Malignant From Benign Pulmonary Nodules and to Monitor Response to Therapy
This clinical trial will assess the performance of a liquid biopsy assay to identify cancer in indeterminant pulmonary nodules identified by CT screening of high-risk individuals and evaluate the capability of the liquid biopsy assay to monitor response to surgical resection.
This clinical study examines the feasibility of a liquid biopsy methylation assay to detect non-small lung cancer. First, the investigators will apply their liquid biopsy assay to screen for lung cancer in indeterminate pulmonary nodules suspicious for cancer. Second, the investigators will assess the utility of liquid biopsy to assess tumor dynamics after surgical resection with curative intent. Third, the investigators will assess the presence or absence of this methylation assay in healthy normal persons without a history of lung cancer. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01652820 -
Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT01402089 -
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
|
Phase 4 | |
| Completed |
NCT01257139 -
Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments
|
Phase 3 | |
| Completed |
NCT01662635 -
Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)
|
||
| No longer available |
NCT04667234 -
Expanded Access of Sotorasib
|